Business
Further re ECOpharma Inc, Japan
Further re ECOpharma Inc, Japan.
About this update from Eco Animal Health Group Plc
[{"type":"text","content":"\n \n \n Further re ECOpharma Inc, Japan\n \n \n\n \n Eco Animal Health Group Plc\n \n \n\n \n \n \n 14 March 2011\n \n \n ECO Animal Health Group plc\n \n \n Japanese subsidiary unaffected by earthquake\n \n \n ECO Animal Health Group plc can confirm that the staff and facilities of \n its Japanese subsidiary, Ecopharma, have not been affected by the recent \n tragic events in that country.\n \n \n Ecopharma, which is based in Tokyo, was purchased in December 2009 and \n the company delivered its maiden six months contribution to the first \n half of ECO Animal Health Group plc’s year to 31 March 2011. Ecopharma \n has traded satisfactorily in the second half of the year and is expected \n to deliver a full year result in line with its budget.\n \n \n Ecopharma is a major distributor in Japan of pharmaceutical products for \n animals including Aivlosin®, ECO’s patented macrolide \n antibiotic.\n \n \n Contacts:\n \n \n \n \n ECO Animal Health Group plc\n \n \n  \n \n \n  \n \n \n Marc Loomes\n \n \n  \n \n \n 020 8447 8899\n \n \n \n \n  \n \n \n \n \n Spiro Financial\n \n \n \n \n \n \n Anthony Spiro\n \n \n \n \n 020 8336 6196\n \n \n \n \n  \n \n \n \n \n Cenkos Securities plc\n \n \n \n \n \n \n Stephen Keys / Elizabeth Bowman\n \n \n \n \n 020 7397 8926\n \n \n \n \n (Nominated Adviser)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n ECO Animal Health Group plc is a leader in the development, registration \n and marketing of pharmaceutical products for animals. Our products for \n these global growth markets promote well-being. Our financial goals are \n achieved through the careful and responsible application of science to \n generate value for our shareholders.\n \n \n \n \n \n ","length":3888,"tagName":"div"}]